BIORASI, LLC
AVENTURA, FLORIDA

BIORASI, LLC is a Clinical Research Organization (CRO) distinguished by its commitment to optimizing clinical trials through a combination of advanced technology, professional management, and skilled project teams. Founded in 2002 by technology entrepreneur Boris N. Reznik, Biorasi was established to expedite the process of delivering safe, effective, and reliable therapies to market for pharmaceutical and biotechnology companies. Over its history, Biorasi has focused on refining clinical trial processes, aiming to optimize cost, time, and risk throughout each phase. With offices in major regulatory jurisdictions globally, Biorasi combines the personal touch of a boutique CRO with the scale of leading full-service organizations, enabling it to run trials worldwide. This global presence provides experience across diverse regulatory environments, allowing Biorasi to excel even in challenging climates. The company's unique approach—Clinical Research Optimized™—merges proprietary technology (TALOS™), rigorous staff training, and a culture built around employee ownership. These elements are designed to accelerate trial completion and enhance the likelihood of drug approvals. Recognized for its expert capability in turning around troubled trials where larger CROs might falter, Biorasi has gained recognition as a trial rescue expert. This proficiency not only saves time and money but also preserves entire drug development programs at risk. Biorasi's management is guided by an esteemed board featuring industry luminaries such as Dr. Kurt Ghelsen, who specializes in oncology; Dr. Russel Kaufman, focused on health and medicine investments; and Doug Klinger, a veteran in healthcare entrepreneurship. BIORASI operates under the incorporation number L02000034035 with its principal office at 19505 Biscayne Blvd., Aventura, FL. It was incorporated on December 18, 2002, remains active, and is last updated to have executed an annual report as of April 19, 2024._